SCIEX and Phytronix Improve High-Throughput Pharmaceutical Application

SCIEX and Phytronix Technologies today announced the integration of Phytronix’s LDTD (Laser Diode Thermal Desorption) ion source with SCIEX’s DiscoveryQuant™ Software.

October 15, 2012

SCIEX, a global leader in life science analytical technologies,and Phytronix Technologies today announced the integration of Phytronix's LDTD (Laser Diode Thermal Desorption) ion source with SCIEX's DiscoveryQuantTM Software, giving discovery pharmaceutical scientists a faster, more streamlined method development process with automated method optimizationthan previously available for early ADME workflows. The new solution was launched this week at the AAPS 2012 conference.

This represents the next step for SCIEX and its partner Phytronix to offer the high-throughput market a better alternative than other technologies.  This joint solutionis ideally suited for laboratories that run thousands of samples per day in a regulated environment, especially those with the need for global connectivity to compound database libraries.

The integration gives scientists the ability to use DiscoveryQuant Software to control the LDTD source - and when coupled with the SCIEX Triple QuadTM and QTRAP® mass spectrometry portfolio -to achieve speeds that rival any other product for high-throughput applications in the market today, with sample-to-sample cycle times as low as four seconds.  This MS/MS (tandem mass spectrometry) solution bypasses LC (liquid chromatography) time scales, providing a much faster approach to method development and optimization.  It is expected to improve efficiency and boost productivity.

"We are delivering on the promise of our initial collaboration announcement with SCIEX one year ago," said Jean Lacoursiere, President of Phytronix Technologies.  "We are delivering a more comprehensive and truly unmatched tool for drug discovery.  We are proving that LDTD-MS/MS is a winning combination." 

By combining the LDTD source with DiscoveryQuant software, it is possible to automatically determine optimal ion path parameters for maximum sensitivity while populating a shared central database with this critical information. DiscoveryQuant can then access this method database for the use in assays with the LDTD source.  The output of this new LDTD-MS/MS workflow feeds into compound database libraries that pharmaceutical scientists need to advance their drug discovery & development work and allows researchers to share MS/MS methodologies globallyonline, no matter whether one lab is in Asia, another in the US and a third lab in Europe. 

"Working with innovative front-end source providerssuch as Phytronix is part of SCIEX's commitment to the high-throughput market," said Dave Hicks, Vice President of the Pharmaceutical and Academic Business at SCIEX.  "With our expertise in software for MS/MS applications, we have extended our partnership with Phytronix to give pharmaceutical scientists access to a novel workflow that pushes the limits."

About Phytronix

Founded in 2000, Phytronix Technologies Inc. is a privately-owned company based in Quebec City, province of Quebec, Canada. The company produces and markets laboratory scientific instruments and exports LDTD Technology around the world. Since its establishment, the company shows a growth of 20% to 40% per year.Follow Phytronix on Twitter @Phytronix


SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.

With over 40 years of proven innovation, SCIEX excels by listening to and understanding the ever-evolving needs of its customers to develop reliable, sensitive and intuitive solutions that continue to redefine what is achievable in routine and complex analysis. For more information, please visit

SCIEX social: @SCIEXnewsLinkedIn, and Facebook.

AB Sciex is operating as SCIEX.
© 2018 AB Sciex. The trademarks mentioned herein are the property of the AB Sciex Pte. Ltd. or their respective owners. AB Sciex™ is being used under license.

For research use only. Not for use in diagnostic procedures.

Contact Information
Lulu VanZandt
Program Manager, Brand, Public Relations and Social Media, SCIEX
+1 (508) 383-7163
M: +1 (508) 782-9484